Basic and Clinical Characteristics of PDE 3 Inhibitors as Cardiotonic Agents Masao Endoh Editorial 17 May 2007 Pages: 135 - 139
Atorvastatin-induced Downregulation of Survivin and Vascular Smooth Muscle Cell Apoptosis: A Causal Relationship in Restenosis? Wolfgang Erl Editorial 08 May 2007 Pages: 141 - 144
The Mechanism Underlying Vascular Smooth Muscle Cell Apoptosis Induced by Atorvastatin may be Mainly Associated with Down-regulation of Survivin Expression Yi-Guan XuSheng-Hua ZhouShang Chen OriginalPaper 20 March 2007 Pages: 145 - 153
Oral Administration of Candesartan Improves the Survival of Mice with Viral Myocarditis through Modification of Cardiac Adiponectin Expression Seiichiro SaegusaYu FeiTsugiyasu Kanda OriginalPaper 05 May 2007 Pages: 155 - 160
Beyond Lipid Lowering: The Anti-Hypertensive Role of Statins Vineet ChopraPalak U. ChoksiErdal Cavusoglu REVIEW 28 April 2007 Pages: 161 - 169
Myocardial Phosphodiesterases and Regulation of Cardiac Contractility in Health and Cardiac Disease Oleg E. Osadchii Review 21 March 2007 Pages: 171 - 194
Atherosclerosis and Oxidant Stress: The End of the Road for Antioxidant Vitamin Treatment? Mika J. ThomsonValentina PuntmannJuan-Carlos Kaski Review 05 May 2007 Pages: 195 - 210
Anti-inflammatory Actions of Quinapril Jesus EgidoMarta Ruiz-Ortega Review 03 April 2007 Pages: 211 - 220
Design and Rationale of the ARBITER 6 Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS) Patrick J. DevineMark A. TurcoAllen J. Taylor OriginalPaper 03 April 2007 Pages: 221 - 225
